Ikerian

Ikerian (formerly RetinAI) harnesses the power of machine learning to transform the way doctors detect eye diseases. Trained with a dataset of tens of thousands of patients provided by renowned eye clinics, Ikerian's algorithms speed up the doctor's workflow, help them organize digital health records and detect eye diseases with an accuracy of 98%. Ikerian's software enhances the image quality of eye scanners to a point where it is as good as machines ten times more expensive.
Ikerian colour logo
Carlos Ciller about Verve Ventures
Verve Ventures has been a great partner in our entrepreneurial journey, adapting their support over the past years with access to talent, resources and a large network of experienced professionals and investors who are proactive contributing to the growth of the company. Verve Ventures' contribution has been instrumental to our success in these complex times.
Founders / Management Carlos Ciller, Sandro De Zanet, Stefanos Apostolopoulos
Sectors Health & Bio, Ophtalmology, Artificial Intelligence
Located in Switzerland, France, Canada
Co-Investors BtoV
Follow On

LinkedIn

Sign up to receive our weekly newsletter and learn about investing in technologies that are changing the world.